Skip to main content
. 2021 Feb;11(1):263–276. doi: 10.21037/cdt-20-302

Figure 4.

Figure 4

Interaction of angiotensin II and natriuretic peptide pathways in human heart failure. The detrimental action of angiotensin II via AT1- receptors may be inhibited by AT1-receptor antagonists (e.g., valsartan); the breakdown of natriuretic peptides by action of neprilysin may be inhibited by the neprilysin-inhibitor sacubitril.